WO1999037337A3 - Prostheses with associated growth factors - Google Patents
Prostheses with associated growth factors Download PDFInfo
- Publication number
- WO1999037337A3 WO1999037337A3 PCT/US1999/001391 US9901391W WO9937337A3 WO 1999037337 A3 WO1999037337 A3 WO 1999037337A3 US 9901391 W US9901391 W US 9901391W WO 9937337 A3 WO9937337 A3 WO 9937337A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substrate
- vegf
- growth factor
- growth factors
- endothelial cells
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3808—Endothelial cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3625—Vascular tissue, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3645—Connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3843—Connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Botany (AREA)
- Vascular Medicine (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69934298T DE69934298T2 (en) | 1998-01-27 | 1999-01-21 | GROWTH FACTORS CONTAINING PROSTHESIS |
AU24658/99A AU2465899A (en) | 1998-01-27 | 1999-01-21 | Prostheses with associated growth factors |
EP99904210A EP1051204B1 (en) | 1998-01-27 | 1999-01-21 | Prostheses with associated growth factors |
BR9907273-4A BR9907273A (en) | 1998-01-27 | 1999-01-21 | Prosthesis, article, prosthetic heart valve, and, processes to produce a prosthesis for a human patient, to modify a substrate, to associate endothelial cells with a substrate, to distribute a medical article for use by health care professionals, and to produce a biocompatible material |
JP2000528316A JP2002500929A (en) | 1998-01-27 | 1999-01-21 | Growth factor bound prosthesis |
CA002319000A CA2319000A1 (en) | 1998-01-27 | 1999-01-21 | Prostheses with associated growth factors |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1408798A | 1998-01-27 | 1998-01-27 | |
US09/014,087 | 1998-01-27 | ||
US09/186,810 US7722671B1 (en) | 1998-01-27 | 1998-11-05 | Medical devices with associated growth factors |
US09/186,810 | 1998-11-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999037337A2 WO1999037337A2 (en) | 1999-07-29 |
WO1999037337A3 true WO1999037337A3 (en) | 1999-09-30 |
Family
ID=26685640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/001391 WO1999037337A2 (en) | 1998-01-27 | 1999-01-21 | Prostheses with associated growth factors |
Country Status (10)
Country | Link |
---|---|
US (1) | US7722671B1 (en) |
EP (1) | EP1051204B1 (en) |
JP (1) | JP2002500929A (en) |
CN (1) | CN1289259A (en) |
AU (1) | AU2465899A (en) |
BR (1) | BR9907273A (en) |
CA (1) | CA2319000A1 (en) |
DE (1) | DE69934298T2 (en) |
ES (1) | ES2278435T3 (en) |
WO (1) | WO1999037337A2 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE45130E1 (en) | 2000-02-28 | 2014-09-09 | Jenavalve Technology Gmbh | Device for fastening and anchoring cardiac valve prostheses |
US8834561B2 (en) | 2005-10-28 | 2014-09-16 | Jenavalve Technology Gmbh | Device for the implantation and fixation of prosthetic valves |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
US9138315B2 (en) | 2007-04-13 | 2015-09-22 | Jenavalve Technology Gmbh | Medical device for treating a heart valve insufficiency or stenosis |
US9168130B2 (en) | 2008-02-26 | 2015-10-27 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9265631B2 (en) | 2008-02-26 | 2016-02-23 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9295551B2 (en) | 2007-04-13 | 2016-03-29 | Jenavalve Technology Gmbh | Methods of implanting an endoprosthesis |
US9439759B2 (en) | 2008-02-26 | 2016-09-13 | Jenavalve Technology, Inc. | Endoprosthesis for implantation in the heart of a patient |
US9510947B2 (en) | 2011-10-21 | 2016-12-06 | Jenavalve Technology, Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US9597182B2 (en) | 2010-05-20 | 2017-03-21 | Jenavalve Technology Inc. | Catheter system for introducing an expandable stent into the body of a patient |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
US6375680B1 (en) * | 1998-12-01 | 2002-04-23 | St. Jude Medical, Inc. | Substrates for forming synthetic tissues |
WO2001028604A1 (en) * | 1999-10-15 | 2001-04-26 | The Brigham And Women's Hospital, Inc. | Fresh, cryopreserved, or minimally fixed cardiac valvular xenografts |
US6726718B1 (en) * | 1999-12-13 | 2004-04-27 | St. Jude Medical, Inc. | Medical articles prepared for cell adhesion |
DE10010073B4 (en) | 2000-02-28 | 2005-12-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anchoring for implantable heart valve prostheses |
FR2828263B1 (en) | 2001-08-03 | 2007-05-11 | Philipp Bonhoeffer | DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE |
US7371258B2 (en) | 2001-10-26 | 2008-05-13 | St. Jude Medical, Inc. | Valved prosthesis with porous substrate |
IL162803A0 (en) * | 2002-02-06 | 2005-11-20 | Orbus Medical Technologies Inc | Medical device with coating that promotes endothelial cell adherence and differentiation |
CA2509914A1 (en) * | 2002-12-11 | 2004-06-24 | Ferrosan A/S | Gelatine-based materials as swabs |
US20050013870A1 (en) * | 2003-07-17 | 2005-01-20 | Toby Freyman | Decellularized extracellular matrix of conditioned body tissues and uses thereof |
DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
DE102005052628B4 (en) | 2005-11-04 | 2014-06-05 | Jenavalve Technology Inc. | Self-expanding, flexible wire mesh with integrated valvular prosthesis for the transvascular heart valve replacement and a system with such a device and a delivery catheter |
US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
US8398704B2 (en) | 2008-02-26 | 2013-03-19 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
ES2903231T3 (en) | 2008-02-26 | 2022-03-31 | Jenavalve Tech Inc | Stent for positioning and anchoring a valve prosthesis at an implantation site in a patient's heart |
US11278406B2 (en) | 2010-05-20 | 2022-03-22 | Jenavalve Technology, Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect |
BR112012029896A2 (en) | 2010-05-25 | 2017-06-20 | Jenavalve Tech Inc | prosthetic heart valve for stent graft and stent graft |
US20150230918A1 (en) * | 2011-08-16 | 2015-08-20 | The University Of Kansas | Biomaterial based on aligned fibers, arranged in a gradient interface, with mechanical reinforcement for tracheal regeneration and repair |
WO2013171007A1 (en) | 2012-05-16 | 2013-11-21 | Jenavalve Technology Gmbh | Catheter delivery system for introducing an expandable heart valve prosthesis and medical device for the treatment of a heart valve defect |
CN105491978A (en) | 2013-08-30 | 2016-04-13 | 耶拿阀门科技股份有限公司 | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
EP3288495B1 (en) | 2015-05-01 | 2019-09-25 | JenaValve Technology, Inc. | Device with reduced pacemaker rate in heart valve replacement |
US11065138B2 (en) | 2016-05-13 | 2021-07-20 | Jenavalve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
WO2018138658A1 (en) | 2017-01-27 | 2018-08-02 | Jenavalve Technology, Inc. | Heart valve mimicry |
CN109833518B (en) * | 2018-10-16 | 2020-06-26 | 四川大学 | Method for promoting endothelialization of biological heart valve |
CN110101912B (en) * | 2019-05-16 | 2020-03-10 | 四川大学 | Dry artificial biological heart valve containing endothelialization promoting polypeptide and preparation method thereof |
EP4272772A1 (en) * | 2020-12-31 | 2023-11-08 | Venus MedTech (HangZhou), Inc. | Pro-endothelialization biomaterial, heart valve, and preparation and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986000526A1 (en) * | 1984-07-05 | 1986-01-30 | Caplan Arnold I | Process for adapting soluble bone protein for use in stimulating osteoinduction |
EP0742020A2 (en) * | 1995-04-25 | 1996-11-13 | Nicem Ltd | Prosthesis containing bioabsorbable materials insolubilized without chemical reagents and method of making same |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE788822A (en) * | 1971-09-15 | 1973-03-14 | Dow Corning | STERILE PACKAGING PROCESS FOR SURGICAL DEVICES |
FR2523810B1 (en) * | 1982-03-23 | 1988-11-25 | Carpentier Alain | ORGANIC GRAFT FABRIC AND PROCESS FOR ITS PREPARATION |
US5002582A (en) | 1982-09-29 | 1991-03-26 | Bio-Metric Systems, Inc. | Preparation of polymeric surfaces via covalently attaching polymers |
DE3521684A1 (en) * | 1985-06-18 | 1986-12-18 | Dr. Müller-Lierheim KG, Biologische Laboratorien, 8033 Planegg | METHOD FOR COATING POLYMERS |
US4786287A (en) | 1986-10-10 | 1988-11-22 | Baxter Travenol Laboratories | Process for decreasing residual aldehyde levels in implantable bioprosthetic tissue |
US4798611A (en) | 1986-10-14 | 1989-01-17 | Hancock Jaffe Laboratories | Enhancement of xenogeneic tissue |
US5263992A (en) * | 1986-10-17 | 1993-11-23 | Bio-Metric Systems, Inc. | Biocompatible device with covalently bonded biocompatible agent |
US5147514A (en) | 1987-08-02 | 1992-09-15 | University Of North Carolina | Process for cross-linking collagenous material and resulting product |
US5606026A (en) * | 1988-03-25 | 1997-02-25 | The Institute For Human Genetics And Biochemistry | Natural human IgM antibodies immunoreactive with the Tat protein of HIV-1 |
US5147400A (en) | 1989-05-10 | 1992-09-15 | United States Surgical Corporation | Connective tissue prosthesis |
US5194596A (en) | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
CA2051796A1 (en) | 1990-09-21 | 1992-03-22 | Marvin L. Bayne | Vascular endothelial cell growth factor ii |
US5192312A (en) | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
EP0506477B1 (en) | 1991-03-28 | 1999-06-23 | Merck & Co. Inc. | Vascular endothelial cell growth factor C subunit |
EP0550296A3 (en) | 1991-11-28 | 1993-12-29 | Terumo Corp | Vascular endothelial cells growth factor |
US5308641A (en) * | 1993-01-19 | 1994-05-03 | Medtronic, Inc. | Biocompatibility of solid surfaces |
DE69434538T2 (en) | 1994-03-08 | 2006-08-10 | Human Genome Sciences, Inc. | Vascular endothelial growth factor 2 |
WO1995024873A1 (en) * | 1994-03-14 | 1995-09-21 | Cryolife, Inc. | Treated tissue for implantation and preparation methods |
US5869127A (en) * | 1995-02-22 | 1999-02-09 | Boston Scientific Corporation | Method of providing a substrate with a bio-active/biocompatible coating |
US5607918A (en) | 1995-03-01 | 1997-03-04 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-B and DNA coding therefor |
US5672508A (en) * | 1996-01-23 | 1997-09-30 | Mitotix, Inc. | Inhibitors of cell-cycle progression, and uses related thereto |
US6033719A (en) * | 1996-04-25 | 2000-03-07 | Medtronic, Inc. | Method for covalent attachment of biomolecules to surfaces of medical devices |
WO1998000695A2 (en) * | 1996-07-03 | 1998-01-08 | Massachusetts Institute Of Technology | Tat-sf: cofactor for stimulation of transcriptional elongation by hiv-1 tat |
WO2000030698A1 (en) * | 1998-11-20 | 2000-06-02 | University Of Connecticut | Apparatus and method for control of tissue/implant interactions |
-
1998
- 1998-11-05 US US09/186,810 patent/US7722671B1/en not_active Expired - Fee Related
-
1999
- 1999-01-21 DE DE69934298T patent/DE69934298T2/en not_active Expired - Lifetime
- 1999-01-21 EP EP99904210A patent/EP1051204B1/en not_active Expired - Lifetime
- 1999-01-21 CN CN99802428A patent/CN1289259A/en active Pending
- 1999-01-21 AU AU24658/99A patent/AU2465899A/en not_active Abandoned
- 1999-01-21 WO PCT/US1999/001391 patent/WO1999037337A2/en active IP Right Grant
- 1999-01-21 CA CA002319000A patent/CA2319000A1/en not_active Abandoned
- 1999-01-21 ES ES99904210T patent/ES2278435T3/en not_active Expired - Lifetime
- 1999-01-21 JP JP2000528316A patent/JP2002500929A/en active Pending
- 1999-01-21 BR BR9907273-4A patent/BR9907273A/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1986000526A1 (en) * | 1984-07-05 | 1986-01-30 | Caplan Arnold I | Process for adapting soluble bone protein for use in stimulating osteoinduction |
EP0742020A2 (en) * | 1995-04-25 | 1996-11-13 | Nicem Ltd | Prosthesis containing bioabsorbable materials insolubilized without chemical reagents and method of making same |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE45130E1 (en) | 2000-02-28 | 2014-09-09 | Jenavalve Technology Gmbh | Device for fastening and anchoring cardiac valve prostheses |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
USRE45962E1 (en) | 2005-10-28 | 2016-04-05 | Jenavalve Technology Gmbh | Device for the implantation and fixation of prosthetic valves |
US8834561B2 (en) | 2005-10-28 | 2014-09-16 | Jenavalve Technology Gmbh | Device for the implantation and fixation of prosthetic valves |
US9402717B2 (en) | 2005-10-28 | 2016-08-02 | Jenavalve Technology, Inc. | Device for the implantation and fixation of prosthetic valves |
USRE45790E1 (en) | 2005-10-28 | 2015-11-03 | Jenavalve Technology Gmbh | Device for the implantation and fixation of prosthetic valves |
US9138315B2 (en) | 2007-04-13 | 2015-09-22 | Jenavalve Technology Gmbh | Medical device for treating a heart valve insufficiency or stenosis |
US9295551B2 (en) | 2007-04-13 | 2016-03-29 | Jenavalve Technology Gmbh | Methods of implanting an endoprosthesis |
US9445896B2 (en) | 2007-04-13 | 2016-09-20 | Jenavalve Technology, Inc. | Methods for treating a heart valve insufficiency or stenosis |
US9265631B2 (en) | 2008-02-26 | 2016-02-23 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9168130B2 (en) | 2008-02-26 | 2015-10-27 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
US9439759B2 (en) | 2008-02-26 | 2016-09-13 | Jenavalve Technology, Inc. | Endoprosthesis for implantation in the heart of a patient |
US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
US9597182B2 (en) | 2010-05-20 | 2017-03-21 | Jenavalve Technology Inc. | Catheter system for introducing an expandable stent into the body of a patient |
US9510947B2 (en) | 2011-10-21 | 2016-12-06 | Jenavalve Technology, Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient |
Also Published As
Publication number | Publication date |
---|---|
DE69934298D1 (en) | 2007-01-18 |
WO1999037337A2 (en) | 1999-07-29 |
EP1051204A2 (en) | 2000-11-15 |
JP2002500929A (en) | 2002-01-15 |
AU2465899A (en) | 1999-08-09 |
CN1289259A (en) | 2001-03-28 |
US7722671B1 (en) | 2010-05-25 |
CA2319000A1 (en) | 1999-07-29 |
DE69934298T2 (en) | 2007-07-12 |
ES2278435T3 (en) | 2007-08-01 |
BR9907273A (en) | 2001-09-04 |
EP1051204B1 (en) | 2006-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1999037337A3 (en) | Prostheses with associated growth factors | |
EP1007065A4 (en) | Preparation of collagen | |
ES2102366T3 (en) | SURFACES THAT PRESENT DESIRABLE EFFECTS OF CELL ADHERENCE. | |
AU1466799A (en) | Method for inhibiting calcification of aldehyde-fixed bioprosthetic materials | |
IL130961A0 (en) | Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces | |
WO2002018441A3 (en) | Electroprocessed fibrin-based matrices and tissues | |
NZ337845A (en) | Non-antigenic branched polymer conjugates | |
DE69910045D1 (en) | NEW HETEROAROMATIC FRUCTOSE 1,6-BISPHOSPHATASE INHIBITORS | |
AU8163398A (en) | Inhibitors of alpha4beta1mediated cell adhesion | |
EP1054687B8 (en) | Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas | |
CO4830493A1 (en) | ANTIBODIES AGAINST HUMAN CD40 | |
WO1999008717A3 (en) | Latent reactive polymers with biologically active moieties | |
AU1916899A (en) | Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same | |
AU5906000A (en) | Thrombosis filter having a surface treatment | |
CA2311445A1 (en) | Method for immobilizing mediator molecule on inorganic and metal implant material | |
WO1998046257A8 (en) | Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods | |
HK1042052A1 (en) | Vascular endothelial growth factor-2 | |
CA2290481A1 (en) | Peptide-coated implants and processes for their preparation | |
DE60135019D1 (en) | ELECTRICALLY PROCESSED COLLAGEN | |
WO2000069470A3 (en) | Improved cellular uptake of bioactive agents | |
WO2000063236A3 (en) | Adhesion modulatory peptides and methods for use | |
DE3877765D1 (en) | POLYPEPTIDES WITH A LAMININE EFFECTIVENESS. | |
EP1023005A4 (en) | Method for coating stents with dna and expression of recombinant genes from dna coated stent in vivo | |
WO2000034442A3 (en) | Application of shear flow stress to smooth muscle cells for the production of implantable structures | |
DE69533800D1 (en) | THROMBOSE-RESISTANT SURFACE TREATMENT OF BIOMATERIALS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99802428.7 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2319000 Country of ref document: CA Ref document number: 2319000 Country of ref document: CA Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2000 528316 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999904210 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999904210 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWG | Wipo information: grant in national office |
Ref document number: 1999904210 Country of ref document: EP |